Welcome to Oncogene!
Oncogene publishes the latest developments in cancer research, in particular: cellular oncogenes and their mechanism of activation; structure and function of encoded proteins; oncogenes of DNA and RNA tumor viruses; molecular oncology of human tumors; tumor suppressor genes; growth regulatory genes; cell cycle control; growth factors and receptors; apoptosis; immortalization and cellular senescence.
Impact Factor: 7.932*
Submit to Oncogene.
*2015 Journal Citation Reports® (Thomson Reuters, 2016)
Volume 35, No 50
15 December 2016
ISSN: 0950-9232
EISSN: 1476-5594
2015 Impact Factor 7.932*
15/213 Oncology
12/165 Genetics & Heredity
24/289 Biochemistry & Molecular Biology
25/187 Cell Biology
Editors-in-chief:
Douglas R Green, USA
Justin Stebbing, UK
*2015 Journal Citation Reports® Science Edition (Thomson Reuters, 2016)
FEATURED ARTICLES
Review
Lysosome-associated protein transmembrane-4β OpenOriginal Article
Microglia reprogramming by glioma-derived signals FREEOriginal Article
ACAT-1 is a therapeutic target for pancreatic cancer OpenOriginal Article
Differential functionality of Sos1 and Sos2 in MEFsOriginal Article
Wnt signaling and carboxypeptidase E (CPE)Original Article
SENP1 regulates RB stability and functionNews
Post a video summary of your research
The Oncogene Journal is pleased to announce that authors can now upload video presentations to accompany their article when published. Presentations should provide a short, succinct summary of the research and be uploaded as Supplementary Material. Whilst enhancing reader experience, video summaries also provide an excellent tool for promotion to help increase visibility and reach. Please refer to the journal's Instructions for Authors for technical specifications.
Thank you to our reviewers
We would like to thank all those who took the time to review for Oncogene in 2015. The journal could not exist without the knowledge and critical evaluation that our reviewers provide. Your generosity is much appreciated, and we hope your association with the journal continues in future. Please check the list of reviewers in full.
A study of ovarian cancer in mice demonstrates that oncogenesis through fluctuation in the expression levels of certain proteins negates extracellular stimulation or mutation and defines them as novel prognostic markers in ovarian cancer. Read the article, or see coverage in the Times of India.
A report that mammary tumor cells undergoing epithelial–mesenchymal transition (EMT) in response to transforming growth factor-β (TGF-β1) become activated for targeted migration through the lymphatic system, similar to dendritic cells during inflammation, suggests that p38 MAP kinase inhibition may be a useful strategy to inhibit EMT and lymphogenic spread of tumor cells. Read the article, or the institution's press release.
'Open' option for authors
Oncogene offers authors the option to publish their articles with immediate open access upon publication. Open access articles will also be deposited on PubMed Central at the time of publication and will be freely available immediately. Find out more from our FAQs page.
-
Research and Reviews
Latest research highlights and reviews from the Springer Nature family of journals
-
Genetic risk and longitudinal disease activity in systemic lupus erythematosus using targeted maximum likelihood estimation
- this content is FREE
Source: Gene -
Materials and technologies for soft implantable neuroprostheses
Source: Nature Reviews Materials -
A high-throughput-compatible assay to measure the degradation of endogenous Huntingtin proteins
- this content is FREE
Source: Acta Pharmacologica Sinica
-
Genetic risk and longitudinal disease activity in systemic lupus erythematosus using targeted maximum likelihood estimation